Codi QR

Current insights into monitoring of congenital adrenal hyperplasia

The management of 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, remains challenging as both over- and undertreatment with hormone replacement therapy are associated with short and long-term complications. Monitoring of treatment efficacy typically combine...

Descripció completa

Guardat en:
Autors principals: Quinty M. Leusink, Elke E. W. Verploegen, Bas P. H. Adriaansen, Xinyi Chin, Nike M. M. L. Stikkelbroeck, Paul N. Span, Fred C. G. J. Sweep, Margo Dona, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2026-02-01
Col·lecció:Frontiers in Endocrinology
Matèries:
congenital adrenal hyperplasia (CAH)
21-hydroxylase deficiency (21OHD)
monitoring
biomarkers
reference intervals
Accés en línia:https://www.frontiersin.org/articles/10.3389/fendo.2026.1774145/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars